Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

37 Sökresultat.
Relevans Bedömning Nya först Gamla först

Eligibility Psoriatic Arthritis in Psoriasis NCT01316224

- 2021-06-15 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01316224

PASI Psoriasis MIPSO EudraCT 2014-003022-40

- 2018-06-11 - 1 Formulär, 2 Item-grupper, 33 Dataelement, 1 Språk
Item-grupper: Use of the form, Psoriasis Area and Severity Index
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger PASI: Fredriksson T, Pettersson U: Severe psoria - sis – Oral therapy with a new retinoid. Dermatologica 178; 157: 238–244.

Visit 6 Psoriasis NCT02695940

- 2018-01-22 - 1 Formulär, 8 Item-grupper, 50 Dataelement, 1 Språk
Item-grupper: Administrative data, Medical History and physical exam, Vital signs, ECG, Blood sample, Urine sample, Picture, Signature
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Visit 7 Psoriasis NCT02695940

- 2018-01-22 - 1 Formulär, 3 Item-grupper, 7 Dataelement, 1 Språk
Item-grupper: Administrative data, Medical History and Physical Examination, signature
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Visit 4 Psoriasis NCT02695940

- 2018-01-22 - 1 Formulär, 4 Item-grupper, 22 Dataelement, 1 Språk
Item-grupper: Administrative data, Medical History and Physical examination, Medication, signature
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Visit 5 Psoriasis NCT02695940

- 2018-01-22 - 1 Formulär, 4 Item-grupper, 25 Dataelement, 1 Språk
Item-grupper: Administrative data, Medical History, Medication, signature
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Visit 3 Psoriasis NCT02695940

- 2018-01-21 - 1 Formulär, 5 Item-grupper, 26 Dataelement, 1 Språk
Item-grupper: Administrative data, Medical History, Laboratory, Medication, signature
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Baseline Visit 2 Psoriasis NCT02695940

- 2018-01-21 - 1 Formulär, 9 Item-grupper, 49 Dataelement, 1 Språk
Item-grupper: Administrative data, Eligibility criteria, Treated body regions, Medical History, Randomization, Picture of patient, Vital signs, Medication, signature
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

PASI Score HAUT MS University Hospital Muenster (UKM)

- 2017-12-06 - 1 Formulär, 5 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Head and neck, Trunk, Arms, Legs, PASI Score
Hospital Routine Documentation Form at the University Hospital Muenster. Original Form name: PASI Score HAUT MS. Fredriksson T, Pettersson U: Severe psoria - sis – Oral therapy with a new retinoid. Dermatologica 178; 157: 238–244.

Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis - Eligibility

- 2017-06-04 - 1 Formulär, 2 Item-grupper, 5 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00195507

PBI post Skin MS University Hospital Muenster (UKM)

- 2016-09-22 - 1 Formulär, 2 Item-grupper, 29 Dataelement, 1 Språk
Item-grupper: Adminstrative Data, Treatment Benefit
Hospital Routine Documentation Form at the University Hospital Muenster. Original Form name: PBI post Haut MS.

Physical Examinations MIPSO EudraCT 2014-003022-4 DRKS00007147 - Physical Examinations MIPSO EudraCT 2014-003022-4

- 2016-07-25 - 1 Formulär, 5 Item-grupper, 37 Dataelement, 1 Språk
Item-grupper: Use of the form, Physical Examination, Identification of plaques for sampling, Screening/Termination visit, Laboratory tests
MIPSO Comparative study of bacterial microbiota in the skin and intestines of psoriasis patients before and after systemic treatment with adalimumab or ustekinumab or ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. H. C. Thomas A. Luger

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial